John F Crowley Net Worth & Insider Trades
John F Crowley - Chairman & CEO, Amicus Therapeutics Inc
What is John F Crowley's Net Worth?
The current estimated net worth of Amicus Therapeutics Inc's Chairman & CEO, John F Crowley, is estimated to be about $54.1M . John F Crowley owns about 392,896 units of Amicus Therapeutics Inc common stock. In the last 11 years at Amicus Therapeutics Inc, John F Crowley has sold an estimated value of $18.35M worth.
What is John F Crowley's Past Insider Trading?
John F Crowley's largest purchase order was 449,295 units , worth over $6.44M on October 16, 2017. John F Crowley's largest sale order was 449,295 units , worth over $6.44M on October 16, 2017. In total, John F Crowley has made about 69 transactions over 11 years of their time at Amicus Therapeutics Inc. John F Crowley usually trades in June, with the busiest year in 2008. The most recent transaction was a sale order of 18,970 units , worth over $279.82K on January 2, 2018.
John Crowley
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was John F Crowley's Salary in 2020?
As Chairman & CEO of Amicus Therapeutics Inc, John F Crowley has a total base salary of $719,514 . John F Crowley received compensation valued at about $11,315,124 in 2020 after becoming Chairman & CEO. The vast majority of their compensation came in the form of a bonus of $514,800 , stock awards of $5,479,971 , other earnings, plans or compensations of $2,492,491 , change in pension value of $1,282,843 , and other compensation of $825,505 .
What is John F Crowley's' Mailing Address?
- Mailing address is C/o Amicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury NJ 08512 NJ
Amicus Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Change in Pension Value
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John F. Crowley | 2020 | $719,514 | $514,800 | $5,479,971 | $2,492,491 | $1,282,843 | $825,505 | $11,315,124 |
| John F. Crowley | 2019 | $656,770 | $476,815 | $5,327,948 | $2,334,850 | $234,775 | $821,505 | $9,852,663 |
| John F. Crowley | 2018 | $637,640 | $445,710 | $3,861,699 | $1,654,347 | - | $820,567 | $7,419,963 |
| Daphne Quimi | 2020 | $45 | $228,712 | $1,534,382 | $697,894 | - | $34,639 | $2,947, |
| Daphne Quimi | 2019 | $400,000 | $212,960 | $1,311,492 | $538,808 | - | $17,487 | $2,480,747 |
| Daphne Quimi | 2018 | - | - | - | - | - | - | - |
| Bradley L. Campbell | 2020 | $515, | $368,872 | $2,557,304 | $1,163,159 | - | $33,694 | $4, |
| Bradley L. Campbell | 2019 | $500,877 | $378,788 | $2,254,114 | $987,822 | - | $19,538 | $4,141,139 |
| Bradley L. Campbell | 2018 | $468,109 | $327,209 | $1,411,802 | $604,817 | - | $16,710 | $2,828,646 |
| Hung Do | 2020 | $42 | $187,908 | $1,461,322 | $664,660 | - | $31,248 | $2,772,106 |
| Hung Do | 2019 | $414,625 | $200,678 | $1,393,462 | $574,732 | - | $22,129 | $2,605,626 |
| Hung Do | 2018 | - | - | - | - | - | - | - |
| Ellen S. Rosenberg | 2020 | $452, | $199,051 | $1,461,322 | $664,660 | $87,751 | $20,748 | $2,885,820 |
| Ellen S. Rosenberg | 2019 | $439,213 | $233,837 | $1,393,462 | $610,648 | - | $13,538 | $2,690,698 |
| Ellen S. Rosenberg | 2018 | $426,420 | $208,647 | $996,591 | $426,933 | - | $18,270 | $2,076,862 |
| Jay Barth | 2020 | $366,269 | - | $1,315,184 | $598,197 | - | $641,306 | $2,920,956 |
| Jay Barth | 2019 | $471,621 | $228,265 | $1,229,522 | $538,808 | - | $15,998 | $2,484,214 |
| Jay Barth | 2018 | $457,885 | $192,037 | $996,591 | $426,933 | - | $18,790 | $2,092,236 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1178879/000114036121014545/nc10021408x1_def14a.htm
What are Amicus Therapeutics Inc's Past Insider Trades?
Amicus Therapeutics Inc's most recent insider trade came on March 21, 2023 by Michael Raab who sold 4,408 units worth $49.94K . In the last 16 years, insiders at Amicus Therapeutics Inc have sold an estimated value of $186.76M and bought an estimated value of $193.14M worth of shares. Insider trading is most common in June, with the busiest year in 2008. The most active traders at the company are John Crowley, Executive Chairman, Bradley Campbell, President & CEO, and Daphne Quimi, Chief Financial Officer .
AMICUS THERAPEUTICS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||